ArticleAnnals of hematology2022

Thrombopoietin receptor agonist discontinuation rates and reasons among patients with immune thrombocytopenia: a study of administrative claims linked with medical chart review.

Adam Cuker et al.PubMed ↗Publisher ↗

No numbers read from the abstract.